Literature DB >> 5497549

RNA synthesis in HeLa cells. Pattern in hypertonic medium and its similarity to synthesis during G2-prophase.

T Pederson, E Robbins.   

Abstract

Interphase HeLa cells manifest a stepwise shutoff of RNA synthesis when the tonicity of the extracellular medium is gradually increased. Synthesis of heterogeneous nuclear RNA is most sensitive and is selectively inhibited at 1.5 times isotonicity (450 milliosmols/liter), while 45S ribosomal RNA synthesis is not affected significantly below 2.0 times isotonicity. Transfer RNA synthesis is least sensitive to increased osmolarity and is not completely inhibited until the electrolyte concentration of the medium is elevated to 2.8 times isotonicity. Although the transcription and methylation of 45S ribosomal precursor is unaffected at 1.5 times isotonicity, there is pronounced impairment of its processing into 32S and 18S RNA. Using a refined cell synchronization technique, we have been able to compare these effects of hypertonicity with the shutoff of RNA synthesis which occurs during the G(2)-prophase interval of the cell division cycle. In this case, as with random cells in hypertonic medium, a selective inhibition of heterogeneous nuclear RNA synthesis and slowed processing of 45S ribosomal RNA were found, whereas synthesis of 45S and transfer RNA continued unabated throughout G(2)-prophase. While it is known that RNA synthesis essentially ceases during metaphase, we have noted that transfer RNA synthesis continues in metaphase at 10-15% of the interphase rate, which is of particular interest in view of the relative resistance of this species to hypertonicity. The close correlation between the patterns of cessation of RNA synthesis at mitosis and during exposure to hypertonic medium supports our earlier contention that alteration of intracellular electrolyte levels provides a useful model for studying the mechanism of mitosis.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5497549      PMCID: PMC2108155          DOI: 10.1083/jcb.47.3.734

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  28 in total

1.  EVIDENCE FOR TWO DNA-DEPENDENT RNA POLYMERASE ACTIVITIES IN ISOLATED RAT-LIVER NUCLEI.

Authors:  C C WIDNELL; J R TATA
Journal:  Biochim Biophys Acta       Date:  1964-07-22

2.  MITOTICALLY SYNCHRONIZED MAMMALIAN CELLS: A SIMPLE METHOD FOR OBTAINING LARGE POPULATIONS.

Authors:  E ROBBINS; P I MARCUS
Journal:  Science       Date:  1964-05-29       Impact factor: 47.728

3.  Deoxyriboside control and synchronization of mitosis.

Authors:  N XEROS
Journal:  Nature       Date:  1962-05-19       Impact factor: 49.962

4.  Demonstration of an unstable RNA and of a precursor to ribosomal RNA in HeLa cells.

Authors:  K SCHERRER; H LATHAM; J E DARNELL
Journal:  Proc Natl Acad Sci U S A       Date:  1963-02-15       Impact factor: 11.205

5.  POLYRIBOSOMES IN NORMAL AND POLIOVIRUS-INFECTED HELA CELLS AND THEIR RELATIONSHIP TO MESSENGER-RNA.

Authors:  S Penman; K Scherrer; Y Becker; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1963-05       Impact factor: 11.205

6.  Multiple forms of DNA-dependent RNA polymerase in eukaryotic organisms.

Authors:  R G Roeder; W J Rutter
Journal:  Nature       Date:  1969-10-18       Impact factor: 49.962

7.  Synthesis of DNA-like RNA in synchronized cultures of mammalian cells.

Authors:  L J Bello
Journal:  Biochim Biophys Acta       Date:  1968-03-18

8.  RNA synthesis in synchronously growing populations of HeLa S3 cells. II. Rate of synthesis of individual RNA fractions.

Authors:  S E Pfeiffer
Journal:  J Cell Physiol       Date:  1968-02       Impact factor: 6.384

9.  The effects of methionine deprivation on ribosome synthesis in HeLa cells.

Authors:  M H Vaughan; R Soeiro; J R Warner; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1967-10       Impact factor: 11.205

10.  The regulation of RNA synthesis and processing in the nucleolus during inhibition of protein synthesis.

Authors:  M Willems; M Penman; S Penman
Journal:  J Cell Biol       Date:  1969-04       Impact factor: 10.539

View more
  7 in total

1.  Cell transformation by viruses. I. Significance of virus-specific antigens induced by deoxyribonucleic acid-containing tumor viruses. II. Complementary ribonucleic acid in cells transformed by ribonucleic acid-containing tumor viruses.

Authors:  J L Melnick; J S Butel; S S Tevethia; N Biswal; M Benyesh-Melnick
Journal:  In Vitro       Date:  1971 Mar-Apr

2.  Dynamic Crowding Regulates Transcription.

Authors:  Anne R Shim; Rikkert J Nap; Kai Huang; Luay M Almassalha; Hiroaki Matusda; Vadim Backman; Igal Szleifer
Journal:  Biophys J       Date:  2019-11-15       Impact factor: 4.033

3.  Effects of lithium chloride on normal and neoplastic cells in vitro.

Authors:  J Huot; G Nosal; S Radoucu-Thomas
Journal:  Experientia       Date:  1972-04-15

4.  [Comparison of specific synthesis of RNA in synchronized Euglena gracilis (Z) grown on lactate medium in the dark and in the light, and a study of the mitochondria].

Authors:  G Ledoigt; R Calvayrac; A M Orcival-Lafont; B Pineau
Journal:  Planta       Date:  1972-09       Impact factor: 4.116

5.  Chromatin domains and the interchromatin compartment form structurally defined and functionally interacting nuclear networks.

Authors:  Heiner Albiez; Marion Cremer; Cinzia Tiberi; Lorella Vecchio; Lothar Schermelleh; Sandra Dittrich; Katrin Küpper; Boris Joffe; Tobias Thormeyer; Johann von Hase; Siwei Yang; Karl Rohr; Heinrich Leonhardt; Irina Solovei; Christoph Cremer; Stanislav Fakan; Thomas Cremer
Journal:  Chromosome Res       Date:  2006-11-22       Impact factor: 4.620

6.  A method for improving synchrony in the G2 phase of the cell cycle.

Authors:  T Pederson; E Robbins
Journal:  J Cell Biol       Date:  1971-06       Impact factor: 10.539

Review 7.  Specificity factors in cytoplasmic polyadenylation.

Authors:  Amanda Charlesworth; Hedda A Meijer; Cornelia H de Moor
Journal:  Wiley Interdiscip Rev RNA       Date:  2013 Jul-Aug       Impact factor: 9.957

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.